MVDr. Boris Tichý, Ph.D.
Head of Core Facility, Genomics Core Facility
Office: bldg. E35/254
Kamenice 753/5
625 00 Brno
Phone: | +420 53223549498317 |
---|---|
E‑mail: |
Total number of publications: 279
2021
-
Selective Activation of CNS and Reference PPARGC1A Promoters Is Associated with Distinct Gene Programs Relevant for Neurodegenerative Diseases
International Journal of Molecular Sciences, year: 2021, volume: 22, edition: 7, DOI
-
STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma
Leukemia, year: 2021, volume: 35, edition: 5, DOI
-
Thyroid and androgen receptor signaling are antagonized by mu-Crystallin in prostate cancer
International journal of cancer, year: 2021, volume: 148, edition: 3, DOI
2020
-
Analysis mutational landscape in systemic anaplastic large cell lymphoma identifies novel prognostic markers
Year: 2020, type: Conference abstract
-
Dynamika vývoje mutací TP53 u pacientů s chronickou lymfocytární leukemií během léčby BCR inhibitory.
Year: 2020, type: Conference abstract
-
Minor-clone TP53 mutations in CLL patients entering first-line treatment: clonal evolution and clinical impact.
Year: 2020, type: Conference abstract
-
Nuclear inclusions of pathogenic ataxin-1 induce oxidative stress and perturb the protein synthesis machinery
Redox Biology, year: 2020, volume: 32, edition: MAY 2020, DOI
-
Ověřená metodika RT-LAMP Detekce viru SARS-CoV-2019
Year: 2020, type:
2019
-
Analysis of Mutational Landscape in Systemic Anaplastic Large Cell Lymphoma Identifies Novel Prognostic Markers.
Year: 2019, type: Conference abstract
-
Dynamika vývoje mutací TP53 u pacientů s chronickou lymfocytární keukémií během léčby BCR inhibitory.
Year: 2019, type: Conference abstract